info@aurevixpeptides.com
EspañolRead references
Illustrative vial: CJC-1295 Without DACCJC-1295 Without DAC

Illustrative presentation

INFORMATIONAL REFERENCE

CJC-1295 Without DAC

This entry concerns GHRH-related signaling without the DAC modification. Understanding the precise molecule matters because published long-acting CJC-1295 results cannot be transferred directly to the non-DAC form.

Research focus & potential applications

GHRH pathway
Molecular distinctions

What the research shows

Explore the selected studies, their findings and their limits.

Read the findings & sourcesIdentity or formulation distinction

This name is commonly used for a modified GHRH fragment lacking the albumin-binding DAC group. The frequently cited CJC-1295 human study tested the long-acting DAC form, so its duration and hormone results cannot be assigned to this entry. A verified sequence and a study of the matching molecule are needed before describing formulation-specific outcomes.

For more information, contact info@aurevixpeptides.com.

Editorial review: September 23, 2026